drugset / Trial / NCT05602818
A Study of Soticlestat in Healthy Adult Nondependent Recreational Drug Users With Central Nervous System (CNS) Depressant Experience
RandomizedCrossoverDouble-blindOther
Summary
The main aim is to evaluate the relative abuse potential of soticlestat in healthy adults who has used central nervous system (CNS) depressants for recreational nontherapeutic reasons.
Timeline
- Start
- 2022-11-15
- Primary completion
- 2023-06-29
- Completion
- 2023-07-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Alprazolam | Small molecule | 2 mg | Oral |
| Subject | Soticlestat | Small molecule | 300 mg | Oral |
| Subject | Soticlestat | Small molecule | 600 mg | Oral |
| Subject | Soticlestat | Small molecule | 900 mg | Oral |
Indications
No indication recorded.